Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy

References

• Garman KS, Nevins JR, Potti A. Genomic strategies for personalized cancer therapy. Hum Mol Genet 2007; 16: R226–R232
   PubMed Web of Science ®Google Scholar
• Swanton C, Szallasi Z, Brenton JD, Downward J. Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer. Breast Cancer Res 2008; 10: 214
   PubMed Web of Science ®Google Scholar
• Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, et al. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: A substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol 2007; 8: 1071–1078
   PubMed Web of Science ®Google Scholar
• Goldstein LJ, Gray R, Badve S, Childs BH, Yoshizawa C, Rowley S, Shak S, Baehner FL, Ravdin PM, Davidson NE, et al. Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol 2008; 26: 4063–4071
   PubMed Web of Science ®Google Scholar
• Mendiratta P, Febbo PG. Genomic signatures associated with the development, progression, and outcome of prostate cancer. Mol Diagn Ther 2007; 11: 345–354
   PubMed Web of Science ®Google Scholar
• Anguiano A, Nevins JR, Potti A. Toward the individualization of lung cancer therapy. Cancer 2008; 113: S1760–S1767
   PubMed Web of Science ®Google Scholar
• Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, et al. Erlotinib in lung cancer - Molecular and clinical predictors of outcome. New England Journal of Medicine 2005; 353: 133–144
   PubMed Web of Science ®Google Scholar
• Dressman HK, Berchuck A, Chan G, Zhai J, Bild A, Sayer R, Cragun J, Clarke J, Whitaker RS, Li L, et al. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol 2007; 25: 517–525
   PubMed Web of Science ®Google Scholar
• Turnbull LW. Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed 2009; 22: 28–39
   PubMed Web of Science ®Google Scholar
• Paldino MJ, Barboriak DP. Fundamentals of quantitative dynamic contrast-enhanced MR imaging. Magn Reson Imaging Clin N Am 2009; 17: 277–289
   PubMed Web of Science ®Google Scholar
• Soares D, Law M. Magnetic resonance spectroscopy of the brain: Review of metabolites and clinical applications. Clin Radiol 2009; 64: 12–21
   PubMed Web of Science ®Google Scholar
• Raghunand N. Tissue pH measurement by magnetic resonance spectroscopy and imaging. Methods Mol Med 2006; 124: 347–364
   PubMedGoogle Scholar
• Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging 2006; 33: S27–S37
   PubMed Web of Science ®Google Scholar
• Larson SM, Schoder H. New PET tracers for evaluation of solid tumor response to therapy. Q J Nucl Med Mol Imaging 2009; 53: 158–166
   PubMed Web of Science ®Google Scholar
• Krohn KA, Link JM, Mason RP. Molecular imaging of hypoxia. J Nucl Med 2008; 49: S129–S148
   PubMed Web of Science ®Google Scholar
• Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumours. Eur Radiol 2007; 17: 861–872
   PubMed Web of Science ®Google Scholar
• Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 2006; 47: 989–998
   PubMed Web of Science ®Google Scholar
• Brown JQ, Wilke LG, Geradts J, Kennedy SA, Palmer GM, Ramanujam N. Quantitative optical spectroscopy: A robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. Cancer Res 2009; 69: 2919–2926
   PubMed Web of Science ®Google Scholar
• Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R. Imaging in breast cancer: Diffuse optics in breast cancer: Detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 2005; 7: 279–285
   PubMed Web of Science ®Google Scholar
• Brown JQ, Vishwanath K, Palmer GM, Ramanujam N. Advances in quantitative UV-visible spectroscopy for clinical and pre-clinical application in cancer. Curr Opin Biotechnol 2009; 20: 119–131
   PubMed Web of Science ®Google Scholar
• Ohtsubo T, Saito H, Tanaka N, Kano E. Application of the ATP-bioluminescence assay to thermosensitivity testing for head and neck cancer. Eur Arch Oto-Rhino-Laryngol 1996; 253: 278–282
   PubMed Web of Science ®Google Scholar
• Vaupel P, Okunieff P, Neuringer LJ. In Vivo P-31-NMR spectroscopy of muring tumors before and after localized hyperthermia. Int J Hyperthermia 1990; 6: 15–31
   PubMed Web of Science ®Google Scholar
• Sijens PE, Bovee W, Seijkens D, Koole P, Los G, Vanrijssel RH. Murine mammary tumor response to hyperthermia and radiotherapy evaluated by in vivo P-31 nuclear magnetic resonance spectroscopy. Cancer Research 1987; 47: 6467–6473
   PubMed Web of Science ®Google Scholar
• Prescott DM, Charles HC, Sostman HD, Dodge RK, Thrall DE, Page RL, Tucker JA, Harrelson JM, Leopold KA, Oleson JR, et al. Therapy monotiring in human and canine soft-tissue sarcomas using magnetic resonance imaging and spectroscopy. International Journal of Radiation Oncology Biology Physics 1994; 28: 415–423
   PubMed Web of Science ®Google Scholar
• Baur A, Stabler A, Wendtner CM, Arbogast S, Rahman SA, Santl M, Issels R, Reiser M. MR-imaging changes of musculoskeletal soft-tissue sarcomas associated with neoadjuvant chemotherapy and hyperthermia. Int J Hyperthermia 2003; 19: 391–401
   PubMed Web of Science ®Google Scholar
• Craciunescu O, Blackwell K, Jones EL, MacFall J, Yu D, Vujaskovic Z, Wong TZ, Liotcheva VB, Rosen E, Prosnitz L, et al. DCE-MRI Parameters Have Potential to Predict Response of Locally Advanced Breast Cancer Patients to Neoadjuvant Chemotherapy and Hyperthermia: A Pilot Study [Response]. Int J Hyperthermia 2009; 25(6)405–415
   PubMed Web of Science ®Google Scholar
• Jones DN, Brizel DM, Charles HC, Dewhirst MW, Friedman HS, McCowage G, et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcomas using fluorine-18 FDG PET. J Nucl Med. May, 1996; 37(9)P38
   PubMed Web of Science ®Google Scholar
• Jones DN, McCowage GB, Sostman HD, Brizel DM, Layfield L, Charles HC, Dewhirst MW, Prescott DM, Friedman HS, Harrelson JM, et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 1996; 37: 1438–1444
   PubMed Web of Science ®Google Scholar
• Westerterp M, Omloo JM, Sloof GW, Hulshof MC, Hoekstra OS, Crezee H, Boellaard R, Vervenne WL, Kate ten, van Lanschot FJJJ. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET. Int J Hyperthermia 2006; 22: 149–160
   PubMed Web of Science ®Google Scholar
• Amthauer H, Denecke T, Rau B, Hildebrandt B, Hunerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 2004; 31: 811–819
   PubMed Web of Science ®Google Scholar
• Gooley T, Leisenring W, Crowley J, Storer B. Estimation of failure probabilities in the presence of competing risks: New representations of the old estimators. Statist Med. 1999; 18: 695–706
   PubMed Web of Science ®Google Scholar
• Eschmann SM, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G, Machulla HJ, Bares R. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 2005; 46: 253–260
   PubMed Web of Science ®Google Scholar
• Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, Peters LJ. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006; 24: 2098–2104
   PubMed Web of Science ®Google Scholar
• Lee N, Nehmeh S, Schoder H, Fury M, Chan K, Ling CC, Humm J. Prospective Trial Incorporating Pre-/Mid-Treatment [(18)F]-Misonidazole Positron Emission Tomography for Head-and-Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009; 75(1)101–108
   PubMed Web of Science ®Google Scholar
• Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996; 56: 941–943
   PubMed Web of Science ®Google Scholar
• Thrall DE, Larue SM, Pruitt AF, Case B, Dewhirst MW. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Int J Hyperthermia Aug, 2006; 22: 365–373
   PubMed Web of Science ®Google Scholar
• Lora-Michiels M, Yu D, Sanders L, Poulson JM, Azuma C, Case B, Vujaskovic Z, Thrall DE, Charles HC, Dewhirst MW. Extracellular pH and P-31 magnetic resonance spectroscopic variables are related to outcome in canine soft tissue sarcomas treated with thermoradiotherapy. Clin Cancer Res 2006; 12: 5733–5740
   PubMed Web of Science ®Google Scholar
• Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 349–353
   PubMed Web of Science ®Google Scholar
• Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, Mueller-Klieser W. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Research 2000; 60: 916–921
   PubMed Web of Science ®Google Scholar
• Walenta S, Chau TV, Schroeder T, Lehr HA, Kunz-Schughart LA, Fuerst A, et al. Metabolic classification of human rectal adenocarcinomas: A novel guideline for clinical oncologists?. J Cancer Res Clin Oncol. Jun, 2003; 129: 321–326
   PubMed Web of Science ®Google Scholar
• Schneiderhan W, Scheler M, Holzmann K, Marx M, Gschwend J, Buchholz M, Gress T, Adler G, Seufferlein T, Oswald F. CD147 sliencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in-vivo and in-vitro models. Gut 2009; 58(10)1391–1398
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Hussien R, Oommen S, Gohil K, Brooks GA. Lactate sensitive transcription factor network in L6 cells: Activation of MCT1 and mitochondrial biogenesis. FASEB J Aug, 2007; 21: 2602–2612
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Matsumoto T, Niwa M, Suzuki Y, Omura N, Hanyu N, Nakada K, Yanaga K, Yamada K, Ohkawa K, et al. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 2004; 101: 1994–2000
   PubMed Web of Science ®Google Scholar
• Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszczyk L, Krupska T. H-1-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. International Journal of Radiation Oncology Biology Physics Apr, 2002; 52: 1271–1276
   PubMed Web of Science ®Google Scholar
• Yokota H, Guo JF, Matoba M, Higashi K, Tonami H, Nagao Y. Lactate, choline, and creatine levels measured by vitro H-1-MRS as prognostic parameters in patients with non-small-cell lung cancer. Journal of Magnetic Resonance Imaging 2007; 25: 992–999
   PubMed Web of Science ®Google Scholar
• Viglianti BL, Lora-Michiels M, Poulson JM, Lan L, Yu D, Sanders L, Craciunescu O, Vujaskovic Z, Thrall DE, Macfall J, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy. Clin Cancer Res 2009; 15: 4993–5001
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Poulson JM, Yu D, Sanders L, Lora-Michiels M, Vujaskovic Z, Jones EL, Samulski TV, Powers BE, Brizel DM, et al. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 480–491
   PubMed Web of Science ®Google Scholar
• Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E. Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A 1986; 83: 3302–3306
   PubMed Web of Science ®Google Scholar
• Kukreti S, Cerussi A, Tromberg B, Gratton E. Intrinsic near-infrared spectroscopic markers of breast tumors. Dis Markers 2008; 25: 281–290
   PubMed Web of Science ®Google Scholar
• Zhou C, Choe R, Shah N, Durduran T, Yu G, Durkin A, Hsiang D, Mehta R, Butler J, Cerussi A, et al. Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. J Biomed Opt 2007; 12: 051903-1–051903-11
   Web of Science ®Google Scholar
• Palmer GM, Viola RJ, Schroeder T, Yarmolenko PS, Dewhirst MW, Ramanujam N. Quantitative diffuse reflectance and fluorescence spectroscopy: Tool to monitor tumor physiology in vivo. J Biomed Opt 2009; 14: 024010-1–024010-8
   Web of Science ®Google Scholar
• Vishwanath K, Yuan H, Barry WT, Dewhirst MW, Ramanujam N. Using Optical Spectroscopy to Longitudinally Monitor Physiological Changes within Solid Tumors. Neoplasia 2009; 11(9)889–900
   PubMed Web of Science ®Google Scholar
• Bartel TB, Haessler J, Brown TL, Shaughnessy JD, Jr., van Rhee F, Anaissie E, Alpe T, Angtuaco E, Walker R, Epstein J, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood 2009; 114: 2068–2076
   PubMed Web of Science ®Google Scholar
• Tzika AA, Astrakas L, Cao HH, Mintzopoulos D, Andronesi OC, Mindrinos M, Zhang JW, Rahme LG, Blekas KD, Likas AC, et al. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. International Journal of Molecular Medicine 2007; 20: 199–208
   PubMed Web of Science ®Google Scholar